Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,803 | 112,707 | 127,114 | 97,090 | 100,899 |
| Marketable Securities | 51,073 | 59,727 | 68,856 | 113,896 | 135,337 |
| Receivables | 39,305 | 49,918 | 20,423 | 26,293 | 20,225 |
| Inventories | 9,406 | 10,005 | 12,141 | 12,553 | 12,337 |
| TOTAL | $238,752 | $237,472 | $238,239 | $260,226 | $275,556 |
| Non-Current Assets | |||||
| PPE Net | 10,119 | 9,873 | 9,513 | 9,609 | 9,305 |
| Investments And Advances | 42,598 | 50,860 | 8,000 | 17,794 | 38,521 |
| Other Non-Current Assets | 1,656 | 1,911 | 1,754 | 1,850 | 1,519 |
| TOTAL | $54,373 | $62,644 | $19,267 | $29,253 | $49,345 |
| Total Assets | $293,125 | $300,116 | $257,506 | $289,479 | $324,901 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,092 | 18,804 | 5,963 | 6,335 | 4,021 |
| Accrued Expenses | 7,824 | 10,866 | 10,222 | 7,793 | 10,433 |
| TOTAL | $46,401 | $49,470 | $27,430 | $24,477 | $28,852 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,120 | 144 | 271 | 342 | 310 |
| Other Non-Current Liabilities | 3,738 | 2,983 | 2,785 | 2,433 | 1,890 |
| TOTAL | $8,187 | $7,581 | $7,531 | $7,328 | $6,934 |
| Total Liabilities | $54,588 | $57,051 | $34,961 | $31,805 | $35,786 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,480 | 38,432 | 37,839 | 33,939 | 33,802 |
| Retained earnings | -363,706 | -321,556 | -276,730 | -229,415 | -181,811 |
| Other shareholders' equity | 126 | -70 | 43 | 25 | 31 |
| TOTAL | $238,537 | $243,065 | $222,545 | $257,674 | $289,115 |
| Total Liabilities And Equity | $293,125 | $300,116 | $257,506 | $289,479 | $324,901 |